Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share (the "Shares")
-
Shares outstanding
-
28,743,490
-
Total 13F shares
-
12,260,874
-
Share change
-
+1,971,429
-
Total reported value
-
$375,856,987
-
Put/Call ratio
-
268%
-
Price per share
-
$30.62
-
Number of holders
-
113
-
Value change
-
+$45,292,958
-
Number of buys
-
76
-
Number of sells
-
65
Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (the "Shares") (ENTA) as of Q1 2015
As of 31 Mar 2015,
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (the "Shares") (ENTA) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,260,874 shares.
The largest 10 holders included
Consonance Capital Management LP, FMR LLC, EAGLE ASSET MANAGEMENT INC, Apex Capital Management, STATE STREET CORP, Invesco Ltd., BlackRock Fund Advisors, MCCLAIN VALUE MANAGEMENT LLC, Krensavage Asset Management, LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
113
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.